These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Eicosanoids in Nonalcoholic Fatty Liver Disease (NAFLD) Progression. Do Serum Eicosanoids Profile Correspond with Liver Eicosanoids Content during NAFLD Development and Progression? Maciejewska D; Drozd A; Skonieczna-Żydecka K; Skórka-Majewicz M; Dec K; Jakubczyk K; Pilutin A; Stachowska E Molecules; 2020 Apr; 25(9):. PubMed ID: 32349225 [TBL] [Abstract][Full Text] [Related]
23. Identification of specialized pro-resolving mediator clusters from healthy adults after intravenous low-dose endotoxin and omega-3 supplementation: a methodological validation. Norris PC; Skulas-Ray AC; Riley I; Richter CK; Kris-Etherton PM; Jensen GL; Serhan CN; Maddipati KR Sci Rep; 2018 Dec; 8(1):18050. PubMed ID: 30575798 [TBL] [Abstract][Full Text] [Related]
24. LC/MS/MS analyses of open-flow microperfusion samples quantify eicosanoids in a rat model of skin inflammation. Pipper C; Bordag N; Reiter B; Economides K; Florian P; Birngruber T; Sinner F; Bodenlenz M; Eberl A J Lipid Res; 2019 Apr; 60(4):758-766. PubMed ID: 30696699 [TBL] [Abstract][Full Text] [Related]
25. Lipoxins and aspirin-triggered 15-epi-lipoxins are the first lipid mediators of endogenous anti-inflammation and resolution. Serhan CN Prostaglandins Leukot Essent Fatty Acids; 2005; 73(3-4):141-62. PubMed ID: 16005201 [TBL] [Abstract][Full Text] [Related]
26. Analysis of cytochrome P450 metabolites of arachidonic acid by stable isotope probe labeling coupled with ultra high-performance liquid chromatography/mass spectrometry. Zhu QF; Hao YH; Liu MZ; Yue J; Ni J; Yuan BF; Feng YQ J Chromatogr A; 2015 Sep; 1410():154-63. PubMed ID: 26253834 [TBL] [Abstract][Full Text] [Related]
27. Metabolipidomic profiling reveals an age-related deficiency of skeletal muscle pro-resolving mediators that contributes to maladaptive tissue remodeling. Markworth JF; Brown LA; Lim E; Castor-Macias JA; Larouche J; Macpherson PCD; Davis C; Aguilar CA; Maddipati KR; Brooks SV Aging Cell; 2021 Jun; 20(6):e13393. PubMed ID: 34075679 [TBL] [Abstract][Full Text] [Related]
28. In Vivo Availability of Pro-Resolving Lipid Mediators in Oxazolone Induced Dermal Inflammation in the Mouse. Homann J; Suo J; Schmidt M; de Bruin N; Scholich K; Geisslinger G; Ferreirós N PLoS One; 2015; 10(11):e0143141. PubMed ID: 26599340 [TBL] [Abstract][Full Text] [Related]
29. Acute severe SARS COVID-19 patients produce pro-resolving lipids mediators and eicosanoids. Regidor PA; De La Rosa X; Santos FG; Rizo JM; Gracia Banzo R; Silva RS Eur Rev Med Pharmacol Sci; 2021 Nov; 25(21):6782-6796. PubMed ID: 34787883 [TBL] [Abstract][Full Text] [Related]
30. HPLC/MS/MS-based approaches for detection and quantification of eicosanoids. Lundström SL; D'Alexandri FL; Nithipatikom K; Haeggström JZ; Wheelock AM; Wheelock CE Methods Mol Biol; 2009; 579():161-87. PubMed ID: 19763475 [TBL] [Abstract][Full Text] [Related]
31. Aspirin modulates production of pro-inflammatory and pro-resolving mediators in endothelial cells. Rood KM; Patel N; DeVengencie IM; Quinn JP; Gowdy KM; Costantine MM; Kniss DA PLoS One; 2023; 18(4):e0283163. PubMed ID: 37098090 [TBL] [Abstract][Full Text] [Related]
32. Mediator lipidomics: search algorithms for eicosanoids, resolvins, and protectins. Serhan CN; Lu Y; Hong S; Yang R Methods Enzymol; 2007; 432():275-317. PubMed ID: 17954222 [TBL] [Abstract][Full Text] [Related]
33. Plasma eicosanoid profiles determined by high-performance liquid chromatography coupled with tandem mass spectrometry in stimulated peripheral blood from healthy individuals and sickle cell anemia patients in treatment. Galvão AF; Petta T; Flamand N; Bollela VR; Silva CL; Jarduli LR; Malmegrim KC; Simões BP; de Moraes LA; Faccioli LH Anal Bioanal Chem; 2016 May; 408(13):3613-23. PubMed ID: 26968567 [TBL] [Abstract][Full Text] [Related]
34. Roles of Specialized Pro-Resolving Lipid Mediators in Autophagy and Inflammation. Recchiuti A; Isopi E; Romano M; Mattoscio D Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32927853 [TBL] [Abstract][Full Text] [Related]
35. Formation of lipoxins and resolvins in human leukocytes. Kahnt AS; Schebb NH; Steinhilber D Prostaglandins Other Lipid Mediat; 2023 Jun; 166():106726. PubMed ID: 36878381 [TBL] [Abstract][Full Text] [Related]
37. Determination of endogenous inflammation-related lipid mediators in ischemic stroke rats using background subtracting calibration curves by liquid chromatography-tandem mass spectrometry. Yang Y; Zhong Q; Mo C; Zhang H; Zhou T; Tan W Anal Bioanal Chem; 2017 Nov; 409(28):6537-6547. PubMed ID: 28871447 [TBL] [Abstract][Full Text] [Related]
38. Synthesis and anti-inflammatory and pro-resolving activities of 22-OH-PD1, a monohydroxylated metabolite of protectin D1. Tungen JE; Aursnes M; Vik A; Ramon S; Colas RA; Dalli J; Serhan CN; Hansen TV J Nat Prod; 2014 Oct; 77(10):2241-7. PubMed ID: 25247845 [TBL] [Abstract][Full Text] [Related]
39. Lipidomic profiling of targeted oxylipins with ultra-performance liquid chromatography-tandem mass spectrometry. Yuan ZX; Majchrzak-Hong S; Keyes GS; Iadarola MJ; Mannes AJ; Ramsden CE Anal Bioanal Chem; 2018 Sep; 410(23):6009-6029. PubMed ID: 30074088 [TBL] [Abstract][Full Text] [Related]
40. Development and validation of a rapid, specific and sensitive LC-MS/MS bioanalytical method for eicosanoid quantification - assessment of arachidonic acid metabolic pathway activity in hypertensive rats. Kij A; Kus K; Czyzynska-Cichon I; Chlopicki S; Walczak M Biochimie; 2020; 171-172():223-232. PubMed ID: 32179167 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]